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We isolated a cDNA clone from grafted mouse skin
that encodes a serine protease homologous to human
C1r. The C1r protease is involved in the activation
of the ®rst component of the classical pathway in the
complement system. In order to identify novel tran-
scripts whose expression is regulated in grafted
mouse skin, we ®rst perfomed differential display
reverse transcription polymerase chain reaction ana-
lysis and obtained 18 partial cDNA clones whose
protein products are likely to play an important role
in allograft rejection. One of these showed signi®cant
sequence homology with human complement C1r
precursor. The other clones displayed no homology
to any known sequences, however. Northern blot
analysis demonstrated that the level of this transcript
was upregulated in day 8 postgrafted skin. The full-
length cDNA 2121 nucleotides in length obtained
from screening a mouse skin cDNA library con-
tained a single open reading frame encoding 707
amino acid residues with a calculated molecular
weight of 80,732 Da. Its deduced amino acid
sequence revealed an 81% identity and 89% similar-
ity to the human C1r counterpart. In particular,
mouse C1r contained His501, Asp559, and Ser656,
which were conserved among this group of serine
proteases. This protein was thus designated as mouse
C1r. We have expressed a truncated fragment of C1r
protein without the N-terminal hydrophobic
sequence in Escherichia coli and generated a polyclonal
antibody against it. Subsequent immunohistochem-
ical analysis con®rmed that mouse C1r was signi®-
cantly expressed 8 d after the skin graft in both
allografted and autografted skins, compared with
normal skins. These collective data suggest that a
component of the complement system, C1r, might
contribute to the graft versus host immune responses
in mice. J Invest Dermatol 116:374±379, 2001
G
enetic disparities between donor and recipient are
readily detected by the host immune system,
resulting in host versus graft and graft versus host
responses. These are manifested in vivo by rejection
of tissue and organ grafts (Nash et al, 1992). The
allograft response is coordinated by an interacting network of
cellular and soluble mediators that result in the ultimate destruction
of the foreign graft (Haeney, 1995). Of central importance to the
initiation as well as perpetuation of this response, however, is the
recognition of polymorphic regions of the allogeneic major
histocompatibility complex (MHC) antigens by host T cells
bearing clonally speci®c T cell receptors (Krensky et al, 1990;
Utku et al, 1998). Recent studies have revealed that T cells speci®c
for allogeneic MHC proteins expressed on transplanted cells
mediate the rejection processes of allografts (Lombardi et al, 1989;
Benichou et al, 1992, 1998; Fangmann et al, 1992). Although the
critical role of T cells in the allograft response has long been
demonstrated, this does not mean that antibodies, B cells, or other
cells play no part in the process (Bladwin et al, 1995; Brauer et al,
1995; Merten et al, 1998). Despite recent advances in our
understanding of the molecular mechanisms underlying T cell
recognition of alloantigens, little is known concerning the actual
contributions of other cells or soluble mediators involved in the
graft rejection in vivo.
The complement system comprises a group of proteins that
promote the in¯ammatory response (Reid and Porter, 1989). The
classical pathway consists of C1, C4, and C2. The C1
macromolecular complex (C1q:C1r2:C1s2) is the product of ®ve
genes, three of them encoding the A, B, and C chains of C1q,
whereas C1r and C1s are encoded by single genes (for a review, see
Schmarker et al, 1987). Two homologous, yet distinct, serine
proteases, C1r and C1s, are assembled into C1s-C1r-C1r-C1s in a
Ca2+-dependent manner. C1r is responsible for intrinsic C1
activation, a two-step process involving ®rst an autolytic C1r
activation and then C1r-mediated cleavage of proenzyme C1s. C1
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is activated upon binding antigen-antibody immune complexes
containing IgM or IgG. In case of the human, C1r is a single-chain
glycoprotein with a molecular weight of approximately 83,000 Da.
Upon activation, it is cleaved into an A chain (Mr 56,000) and a B
chain (Mr 27,000), and these two chains are held together by a
disul®de linkage. Activated C1 can cleave C4 and initiate
subsequent steps of the classical complement pathway. Futhermore,
there is increasing evidence that antibodies can damage grafts
through the activation of complement (Colletti et al, 1994).
Skin is considered to be highly immunogenic. A number of
professional antigen-presenting cells, such as Langerhans cells and
dermal dendritic cells, are involved in skin allograft rejection as well
as various immunologic functions. It is likely that a variety of genes
are involved in the allograft rejection as well. In this study, we
initiated differential display reverse transcription polymerase chain
reaction (ddRT-PCR) approaches to obtain novel transcripts in the
mouse skin grafts and identi®ed a gene clone encoding a
complement C1r component. The mouse C1r was expressed to a
signi®cant level 8 d after the skin graft in both allografted and
autografted mouse skins as determined by northern blot analysis and
immunohistochemical analysis. In contrast, little expression was
observed in normal skins. This suggests that C1r component might
contribute to graft versus host immune responses in mice.
MATERIALS AND METHODS
Animals C3H/HeN and BALB/C male mice aged 8±12 wk were used
in this study and maintained in our pathogen-free facility. Mice were fed by
free access to autoclaved water and food ad libitum.
Skin graft Mouse skin was grafted according to a described method
(Benichou et al, 1998). Brie¯y, full-thickness back skins were harvested
from euthenized donor mice, the subcutaneous fat was removed, and the
skin was cut to 0.5±1 cm2 and placed in RPMI medium until used for
transplantation. Recipient mice were anesthetized; skins were placed in a
slightly larger graft bed prepared over the back of the recipient and stitched
using silk.
For allografts, donor mice were BALB/C and recipient mice were C3H/
HeN. Donor and recipient mice of autografts were BALB/C mice. The
autografted and allografted skins were obtained at day 1 and 8 after skin
transplantation.
Total RNA isolation and ddRT-PCR Total RNAs were isolated
from the autografted and allografted skins as well as from normal BALB/C
skins using TRIzol reagent as instructed by the manufacturer (Gibco-BRL,
Gaithersburg, MD). ddRT-PCR was performed as described previously
(Liang and Pardee, 1992) and as instructed in the Differential Display Kit
(Display Systems Biotech, Los Angeles, CA) with some modi®cations.
Brie¯y, each 5 mg of total RNA from the normal and grafted skins were
®rst treated with RNase-free DNase I (Takara, Ohtsu, Japan) in the
presence of 10 units of ribonuclease inhibitor (Gibco-BRL). The ®rst-
strand cDNAs were prepared from 500 ng of total RNAs using a
Differential Display Kit (Display Systems Biotech) as described by the
manufacturer. The RNA from each sample was incubated with one of nine
downstream primers containing 11T residues and two-nucleotide anchors
(AA, AC, AG, CA, CC, CG, GA, GC, and GG) for 1 h at 37°C, followed
by 5 min at 95°C to inactivate the M-MLV reverse transcriptase (Gibco-
BRL). Each cDNA was subjected to PCR ampli®cation with Ex-Taq
(Takara), using the original downstream primer, one of 24 10-mer 5¢
primers, and [g-35S]-dATP. The 40 rounds of PCR were done at 94°C for
30 s, 40°C for 1 min 30 s, and 72°C for 1 min in a thermocycler (Perkin-
Elmer Model 2400, Roche Diagnostics Systems, Mannheim, Germany),
followed by a ®nal cycle at 72°C for 10 min. The radiolabeled products
were separated on a 6% DNA sequencing gel containing 7 M urea. The gel
was dried and exposed on X-ray ®lm (Fuji, Tokyo, Japan). Bands showing
induced or repressed expression patterns in the allografted groups were cut
out. cDNAs from bands were eluted in 100 ml TE buffer (pH 8.0).
Following ethanol precipitation, the eluted cDNAs were reampli®ed by
PCR using the same primer sets and conditions as described above. The
PCR products were run on agarose gel in order to con®rm the size of the
cDNAs. Each reampli®ed band was puri®ed by Geneclean system (Bio 101,
Vista, CA). Each cDNA was subcloned into pGEM-T Easy Vector
(Promega, Madison, WI) and sequenced by the dideoxynucleotide chain-
termination method (Sanger et al, 1977). The sequences were compared
with the National Center of Biotechnology Information nonredundant
sequence database using the BLASTX and BLASTN programs.
Northern blot analysis Total RNA samples (each 20 mg) from the
normal and grafted skins were electrophoresed in a 1% agarose gel
containing 6% formaldehyde and 1 3 MOPS buffer [1 3 MOPS buffer is
20 mM MOPS, pH 7.0, 5 mM sodium acetate, and 1 mM ethylenediamine
tetraacetic acid (EDTA)]. The RNA was transferred onto a nylon
membrane (Schleicher & Schuell, Dassel, Germany) by capillary action
and covalently ®xed to the membrane by ultraviolet cross-linker
(Spectrolinker, Westbury, NY). The [a-32P]-labeled probes were
prepared using the Prime-a-Gene Labeling System (Promega).
Prehybridization, hybridization, and posthybridization wash of the
membrane were carried out as described previously (Sambrook et al,
1989). Standardization was performed by hybridization of the same
membrane with a probe from mouse glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) cDNA. After autoradiography, quantitation of
the signals was performed by densitometric analysis with Gel Doc 2000 gel
documentation systems (Bio-Rad Lab, Hercules, CA).
Identi®cation of full-length cDNA Phage cDNA library from a
mouse skin in the Uni-ZAP XR vector was screened by plaque
hybridization with a total of 2.5 3 107 plaques (Stratagene, La Jolla, CA).
Both prehybridization and hybridization were done at 42°C. The probe
was the isolated cDNA, which was labeled with [a-32P]-CTP (Amersham-
Pharmacia, Cleveland, OH). After two more puri®cation procedures, the
individual positive plaques were isolated using end-removed tips, and the
l-DNA puri®ed by plaque hybridization was rescued by in vivo excision
using an f1 helper phage. Sequences of the isolated cDNA were determined
by the dideoxynucleotide chain-termination method using T7 Sequenase
version 2.0 under the manufacturer's instruction (Amersham-Pharmacia).
Expression and puri®cation of the recombinant mC1r
protein The open reading frame from an mC1r cDNA clone was
Figure 1. Northern blot analysis of the clone homologous to human
complement Clr precursor. (A) Total RNAs were prepared from
normal, autografted, and allografted mouse skin biopsies at days 1 and 8
post-transplantation. Representative hybridization signals were obtained
from mC1r at the expected position corresponding to an mRNA size of
3 kb. The hybridization signal for GAPDH is shown as a control at the
same blot. (B) Values for mC1r mRNA levels in relation to GAPDH
mRNA levels in the three groups of animals. Lane 1, normal mouse skin;
lane 2, autograft day 1; lane 3, autograft day 8; lane 4, allograft day 1; lane 5,
allograft day 8.
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ampli®ed by PCR with speci®c primers containing a restriction site
(HindIII) added to the 5¢ and 3¢ ends to facilitate cloning of the PCR
product. The forward primers were 5¢- CTGCAGTCGACAAGCT-
TCATATGTGGCTCTTTGCCCTC-3¢ including the signal peptide and
5¢- CAGTCGACAAGCTTCATATGTCCATTTACCTCCCTCAG - 3¢
without the signal peptide, and the reverse primer was 5¢- ATCGAT-
CTCGAGAAGCTTATCAACAATTGG TCAGATAC-3¢. The PCR-
ampli®ed 2.2 kb cDNA was subcloned into a pET28b vector (Novagen)
and introduced into Escherichia coli BL21 cells carrying the DE3
bacteriophage. The ®delity of the expression construct was con®rmed by
DNA sequencing. The protein expression and puri®cation procedure was
performed as described previously (Takai et al, 1998) with some
modi®cation. Upon addition of isopropyl-b-D-thiogalactoside to the
culture, the mC1r recombinant protein was expressed as a fusion with
histidine tagging. Induced cells were harvested by centrifugation, and lyzed
by sonication within 8 M urea, 50 mM Tris-HCl, pH 8.0, and 1 mM
EDTA. The supernatants were adsorbed to the nickel-chelating
chromatography resin (Novagen) after clearing, and the fusion protein
was eluted with 1 M imidazole, 500 mM NaCl, and 20 mM Tris-HCl,
pH 7.9. The expression of the recombinant protein was con®rmed by
western blot analysis with T7´Tag antibody from Novagen followed by
detection using the ECL plus system from Amersham (Amersham Life
Science, Buckinghamshire, U.K.).
Preparation of antirecombinant mC1r antibodies Polyclonal
antisera against the recombinant mC1r protein were obtained from a
New Zealand White rabbit. The nickel-chelation chromatography fraction
containing fused mC1r protein was resolved by 9% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). The corresponding bands
were excised and used to raise a polyclonal antibody in rabbits. Emulsions
were prepared by mixing 0.5 ml of the Freund adjuvant (Gibco-BRL) with
0.5 ml of the excised protein solution (0.5 mg per ml) dissolved in distilled
water. The emulsi®ed antigen was injected intradermally into the back skin
of a rabbit near the neck at 4 wk intervals. The rabbit was bled following
the third injection and biweekly thereafter. The titer of anti-mC1r protein
was evaluated by western blot analysis.
Immunohistochemistry For immunostaining of the skin biopsies from
normal, autografted, and allografted mice, 4 mm cryosections were obtained
from un®xed frozen tissues, allowed to air-dry for 30 min, ®xed in 100%
ice-cold acetone for 10 min at 20°C, and air-dried for 30 min. Sections
were stored at ±20°C and staining was performed as described elsewhere
with minor modi®cations (Ashcroft et al, 1997). Brie¯y, nonspeci®c
binding was blocked with 10% normal donkey serum. Sections were
incubated for 60 min at room temperature with 1:20 diluted polyclonal
primary antibody in antibody diluent reagent solution from Zymed Lab
(South San Francisco, CA). Subsequently, the sections were incubated for
20 min with a biotinylated donkey antirabbit immunoglobulin (DACO,
Carpinteris, CA) for 20 min, followed by horseradish peroxidase labeled
avidin. 3-Amino-9-ethylcarbazole was applied as chromogen under
microscopic control with an Olympus inverted microscope until the
speci®c staining signal was visible. Control staining for each tissue was
performed with the same conditions, except that preimmune rabbit serum
was used as a primary antibody source.
RESULTS
ddRT-PCR and overview of the selected cDNAs Originally
ddRT-PCR was performed as a method to identify novel gene(s)
whose transcription is induced or repressed by the skin
transplantation procedure. cDNAs from normal, syngeneic, and
allogeneic grafted skins on day 1 and 8 post-transplantation were
Figure 2. Nucleotide and deduced amino acid
sequences of the cDNA homologous to hu-
man complement Clr precursor. The cDNA
was screened from the mouse skin cDNA library.
The putative signal peptide and polyadenylation
signal sequences are indicated by underlining. The
three boxed Asn residues are the possible glycosy-
lation sites. The sequence is available from the
GenBank, accession number AF148216
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ampli®ed with a set of arbitrary PCR primers. The PCR products
were resolved by 6% acrylamide sequencing gel containing 7 M urea
and visualized by autoradiography. Eighteen candidate DNA bands
were selected and isolated for further characterization. The selected
cDNAs were approximately 150±400 bp in size. The reampli®ed
PCR products were subjected to subcloning and subsequent
sequencing, followed by BLAST sequence analysis (Altschul et al,
1990) and MasPar searches of the NCBI nonredundant nucleotide
database. Out of 18 candidate genes that were sequenced and
analyzed, 12 were novel sequences without a signi®cant homology
to any known genes in the database (data not shown), and the
others had multiple signi®cant hits. These six products were chosen
for further characterization.
Identi®cation of genes differentially expressed in the grafted
skin Northern blot analysis was performed with total RNA
isolated from the normal autografted and allografted skin using six
selected partial cDNA sequences as probes (data not shown).
Among the six candidate cDNAs, only one clone showing
signi®cant homology to human complement C1r precursor was
highly upregulated in the grafted skin of both syngeneic and
allogeneic mice (Fig 1). The transcript was mobilized as a band of
around 3.0 kb in size similar to that of humans (Journet and Tosi,
1986). Therefore, we attempted to isolate a full-length cDNA for
the mouse homolog to the human complement C1r precursor.
Screening, sequencing, and expression level of the mouse
homolog to human complement C1r precursor In order to
isolate a full-length cDNA encoding mouse C1r, approximately
2.5 3 107 plaques of a mouse skin cDNA library were screened
using a partial cDNA fragment that was obtained from ddRT-PCR
as a probe. Eight positive phage clones were selected in the initial
screening. Two further rounds of phage puri®cation were
performed and a clone containing the longest DNA insert was
identi®ed from the eight positive clones with an insert 400±2400 bp
in size by southern blot analysis (result not shown) and was
designated mC1r. A pBluexcript phagemid of the mC1r from this
clone was constructed by in vivo excision and was used to determine
the nucleotide sequence. The phagemid obtained contained a
cDNA insert approximately 2.4 kb in size that shared a high
sequence homology to human complement C1r precursor (Journet
et al, 1986; Leytus et al, 1986). The mC1r had an open reading
frame of 2121 bp that started with a translation initiation site at
position 167 and could encode a polypeptide with 707 amino acid
residues with a calculated molecular weight of 80,732 Da, including
a typical signal peptide sequence of 16 amino acids at the N-
terminus. The nucleotide and deduced amino acid sequences of
mC1r are shown in Fig 2. The deduced amino acid sequence of
mC1r has an 89% similarity and 81% identity to that of human
complement C1r precursor (Fig 3). This cDNA was identi®ed as
the mouse homolog of human C1r. Its RNA level is rarely
detectable in a normal skin sample as shown in Fig 1. When the
grafted skin samples at the time points of day 1 and 8 post-
transplantation were subjected to northern blot analysis, however,
the RNA level was strongly upregulated. mC1r mRNA levels were
very similar in the autografted and allografted skin according to the
densitometric analysis with GAPDH and mC1r (Fig 1B). This
suggests that mC1r is likely to play a pivotal role in graft versus host
responses following the graft procedure in mice.
In vitro expression of a recombinant mC1r protein From
preliminary studies, our attempts to express in E. coli the full-length
cDNA containing the hydrophobic signal peptide with a size of 707
amino acid residues resulted in only a small amount of recombinant
protein appearing as insoluble aggregates (data not shown). In order
to increase the level of protein expression, we prepared a truncated
construct of 691 amino acid residues without the N-terminal
hydrophobic putative signal peptide sequence. The recombinant
protein was expressed at a relatively high level in the cytosolic
fraction and could be puri®ed by His-Tag chromatography under
denaturing conditions with urea. His-Tag fused protein had
migrated to a band of about 85 kDa in an SDS-PAGE analysis,
which is in agreement with what we calculated from the cDNA
sequence plus the extra 41 amino acid residues from the pET28b
vector. Immunoblot analysis (data not shown) using T7 Tag
antibody con®rmed that the 85 kDa was, in fact, the His-Tag
mC1r. We directly used the recombinant fusion protein in the
preparation of antibody. The 85 kDa band was excised and used to
raise polyclonal antibody against mC1r.
Antibody against recombinant C1r protein and
immunohistochemistry In order to con®rm expression of
C1r in the grafted skin, a polyclonal antibody was raised against the
recombinant His-Tag-fused mC1r protein. The raised polyclonal
antibody was shown to be highly speci®c for the recombinant
protein (data not shown). To con®rm the expression of mC1r in
the skin biopsies harvested from autografted and allografted mice,
immunohistochemistry was performed using an anti-mC1r
polyclonal antibody. On analyzing the skin sections harvested on
day 8 following graft from both autografted and allografted mice,
we found positive staining for mC1r, particularly in the dermis
tissue in the allografted skin (Fig 4B), as well as in the autografted
Figure 3. Sequence alignment of the amino acid sequences of the
isolated mouse cDNA and human complement Clr precursor.
Amino acids that are physicochemically similar are indicated by a plus
symbol. Dashes in the sequences represent gaps introduced to maximize
alignment. Amino acid residues marked with closed diamonds represent
key amino acids conserved in trypsin-type serine protease. The solid arrow
indicates the putative Arg-Ile peptide bond cleaved during the activation of
mC1r.
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skin tissue (data not shown), demonstrating that the skin is
associated with a strong in¯ammation response. mC1r was rarely
detectable in the skin from normal mice, however (Fig 4A). This
suggests that an increase in mC1r expression plays an important role
for graft versus host immune responses in mice.
DISCUSSION
A series of gene products has been suggested to be involved in graft
versus host immune responses. We have performed ddRT-PCR in
order to identify genes that are differentially expressed in grafted
mouse skin. From this procedure, 18 candidate cDNAs were
isolated, cloned, and sequenced, and a sequence similarity search
was performed. The results of a homology search revealed that six
of these cDNAs had a similarity to known genes, whereas the
remaining 12 cDNAs displayed no signi®cant similarity to any
deposited sequences. These six cDNAs were used as probes on
northern blots to detect a differential expression, although only one
showed a difference in its RNA level after the skin graft procedure.
The sequence of this cDNA has a high similarity to that of human
Clr. By northern blot analysis, we have identi®ed the highly
induced expression of its 3.0 kb transcript in the skins on day 8
post-transplantation. The full length of the cDNA designated as
mClr was isolated from a mouse skin cDNA library using a probe of
partial cDNA from ddRT-PCR. It contained no poly (A) tail
region and was in accordance with the size of the transcript that was
detected as a 3.0 kb range by northern blot. By comparison, human
complement Clr precursor contains 705 amino acids, whereas the
mClr encodes a protein with 707 amino acid residues, including a
typical signal peptide sequence of 16 amino acid residues at the N-
terminus. The deduced amino acid sequence of the mClr had 81%
identity and 89% similarity with that of humans. The His501, Asp559,
and Ser656 amino acid residues, conserved in trypsin-type serine
proteases, were also conserved in the mClr as well as the primary
structure of the regions surrounding these key amino acid residues.
The putative N-glycosylation sites (N-X-S/T) of the mClr were
identi®ed as Asn124, Asn220, and Asn583, and the cleavage of A and B
chains is likely to occur between Arg462 and Ile463. In addition, the
number and position of the conserved cysteine residues of serine
proteases in the mClr completely matched those of the human
complement Clr precursor. The expression of mClr was upregu-
lated in the grafted mouse skins. We have previously shown that
type 1 cytokines, such as interleukin-2 (IL-2), interferon-g (IFN-g),
and IL-12, play an important role in skin allograft rejection. A large
variety of cells, including monocytes/macrophages, polymorpho-
nuclear cells, ®broblasts, epithelial cells, keratinocytes, endothelial
cells, and adipose cells, synthesize complement components when
cultivated in vitro (Gasque et al, 1993). This biosynthesis is
constitutive and is enhanced following stimulation by cytokines,
such as IL-1b, IL-6, IFN-g, and tumor necrosis factor a (TNF-a).
Several reports have demonstrated that IFN-g induces increased
biosynthesis of Clr (Legeodec et al, 1997). Taken together, our
results coincide with these ®ndings that stimulation by IFN-g and
the expression of complement mClr are correlated (Hyun et al,
1998). Thus, the components of the classical complement system,
C1q, C1r, C1s, C2, and C4, were upregulated after stimulation
with IFN-g. We suggest that grafted skin tissues may constitute a
local source of these components and therefore they could be
implicated in in¯ammatory or physiopathologic processes devel-
oped in grafted skin in mice.
From the immunohistochemical study, both autografted and
allografted skin tissues were associated with the strong in¯ammatory
process, and the mC1r mRNA and protein were signi®cantly
detectable in the grafted skin tissues, particularly in the dermis
rather than epidermis of the skin, even on day 1 post-transplanta-
tion, suggesting that this complement component is involved in the
early response to the skin graft procedure. The complement system
is one of the four major proteolytic cascades of the blood. Together
with the immunoglobulins, the complement system traditionally
represents the humoral system of the immunologic host defense,
and is involved in many biologic activities contributing to defense
against microbial invaders and to in¯ammatory reactions (Moore,
Figure 4. Expression of mC1r in normal skin
tissue and allografted skin tissue on day 8
post-transplantation. The skin biopsies har-
vested from normal (a, b) and allografted (c, d)
mice were evaluated by immunohistochemistry
using an anti-mC1r polyclonal antibody, which
was raised against the recombinant mC1r protein,
and preimmune rabbit serum as a control anti-
body [e (normal skin tissue) and f (allograft skin
tissue 8 d post-transplantation)]. Magni®cation: a,
c, 403; b, d, e, f, 2003.
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1994). It has been proposed, however, that immune complexes
initiate in¯ammatory responses either via activation of the
complement system (Colten, 1994) or, alternatively, by the direct
engagement and activation of FcR-bearing in¯ammatory cells
(Ravetch and Clynes, 1998). Although the concept of immune-
complex-triggered in¯ammation via activation of the complement
cascade is well established, recent studies in FcR-de®cient mutant
mice have promoted the different view that immune complexes
induce in¯ammation predominantly through FcR engagement,
with complement proteins subserving primarily immunoregulatory
functions (Ravetch and Clynes, 1998). It has been proposed that
the role of the complement system is largely immunoregulatory and
minimally in¯ammation (Matis and Rollins, 1995). Thus, the
expressed mC1r may be involved in this complex graft versus host
immune response. In vitro stimulation of a number of different cell
types with IFN-g by in®ltrating T cells stimulates expression and
production of complement components, such as C1q, C1r, C1s,
C2, and C4. Therefore, the upregulation of the C1r protein level in
completely different skin graft reactions is expected. This is the ®rst
result indicating the involvement of this potent classical pathway for
various physiologic responses in graft versus host immune responses
in mice.
In summary, we cloned mouse Clr homologous to the human
complement Clr precursor, which plays an important role in the
initiation of the activation of the classical pathway. Additionally,
the expression of complement component was upregulated in the
allografted and autografted skin tissues. Further study is required to
elucidate, in detail, the fucntion of mClr in graft versus host
immune responses.
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